ICON plc

210.52-0.4800-0.23%Vol 601.12K1Y Perf -7.94%
May 16th, 2022 16:00 DELAYED
BID160.00 ASK250.01
Open209.01 Previous Close210.52
Pre-Market- After-Market210.52
 - -  - -%
Target Price
286.50 
Analyst Rating
Moderate Buy 1.75
Potential %
36.09 
Finscreener Ranking
★★     46.21
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     40.70
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     53.36
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
10.10 
Earnings Rating
Neutral
Market Cap17.11B 
Earnings Date
27th Apr 2022
Alpha0.01 Standard Deviation0.07
Beta0.97 

Today's Price Range

206.08211.92

52W Range

199.01313.00

5 Year PE Ratio Range

15.3051.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
0.27%
1 Month
-14.44%
3 Months
-8.45%
6 Months
-25.19%
1 Year
-7.94%
3 Years
53.14%
5 Years
143.71%
10 Years
865.69%

TickerPriceChg.Chg.%
ICLR210.52-0.4800-0.23
AAPL145.54-1.5700-1.07
GOOG2 295.85-34.4600-1.48
MSFT261.500.38000.15
XOM90.952.09002.35
WFC42.21-0.4300-1.01
JNJ178.081.23000.70
FB200.041.42000.71
GE74.63-0.4200-0.56
JPM118.26-0.8300-0.70
Financial StrengthValueIndustryS&P 500US Markets
1.10
1.10
0.39
0.66
2.50
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
27.60
5.30
12.00
13.30
2.60
RevenueValueIndustryS&P 500US Markets
6.52B
80.26
27.25
24.63
Earnings HistoryEstimateReportedSurprise %
Q01 20222.482.604.84
Q04 20212.402.441.67
Q03 20212.432.554.94
Q02 20212.102.120.95
Q01 20211.932.066.74
Q04 20201.831.903.83
Q03 20201.551.7210.97
Q02 20201.101.209.09
Earnings Per EndEstimateRevision %Trend
6/2022 QR2.52-76.51Negative
9/2022 QR2.83-77.47Negative
12/2022 FY10.67--
12/2023 FY12.58--
Next Report Date-
Estimated EPS Next Report2.48
Estimates Count1
EPS Growth Next 5 Years %18.20
Volume Overview
Volume601.12K
Shares Outstanding81.29K
Shares Float80.16M
Trades Count10.35K
Dollar Volume126.41M
Avg. Volume536.85K
Avg. Weekly Volume518.56K
Avg. Monthly Volume466.94K
Avg. Quarterly Volume625.04K

ICON plc (NASDAQ: ICLR) stock closed at 210.52 per share at the end of the most recent trading day (a -0.23% change compared to the prior day closing price) with a volume of 601.12K shares and market capitalization of 17.11B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 15730 people. ICON plc CEO is Steven Cutler.

The one-year performance of ICON plc stock is -7.94%, while year-to-date (YTD) performance is -32.02%. ICLR stock has a five-year performance of 143.71%. Its 52-week range is between 199.01 and 313, which gives ICLR stock a 52-week price range ratio of 10.10%

ICON plc currently has a PE ratio of 81.20, a price-to-book (PB) ratio of 2.13, a price-to-sale (PS) ratio of 2.62, a price to cashflow ratio of 16.80, a PEG ratio of 2.32, a ROA of 1.64%, a ROC of 3.53% and a ROE of 3.40%. The company’s profit margin is 2.60%, its EBITDA margin is 12.00%, and its revenue ttm is $6.52 Billion , which makes it $80.26 revenue per share.

Of the last four earnings reports from ICON plc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.48 for the next earnings report. ICON plc’s next earnings report date is -.

The consensus rating of Wall Street analysts for ICON plc is Moderate Buy (1.75), with a target price of $286.5, which is +36.09% compared to the current price. The earnings rating for ICON plc stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ICON plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ICON plc has a Sell technical analysis rating based on Technical Indicators (ADX : 16.19, ATR14 : 10.03, CCI20 : -91.31, Chaikin Money Flow : -0.10, MACD : -8.21, Money Flow Index : 48.30, ROC : -6.46, RSI : 38.71, STOCH (14,3) : 33.34, STOCH RSI : 0.55, UO : 42.04, Williams %R : -66.66), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ICON plc in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (62.50 %)
6 (75.00 %)
8 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (37.50 %)
2 (25.00 %)
4 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.75
Strong Buy
1.50
Moderate Buy
1.67

ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

CEO: Steven Cutler

Telephone: +353 12912000

Address: South County Business Park, Dublin 18, , IE

Number of employees: 15 730

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

65%35%

Bearish Bullish

69%31%

TipRanks News for ICLR

Sat, 30 Apr 2022 03:55 GMT Icon (ICLR) Gets a Buy Rating from Robert W. Baird

- TipRanks. All rights reserved.

Mon, 21 Mar 2022 12:35 GMT Analysts Offer Insights on Healthcare Companies: Icon (ICLR), United Therapeutics (UTHR) and Legend Biotech (LEGN)

- TipRanks. All rights reserved.

Sat, 05 Mar 2022 09:01 GMT Analysts Are Bullish on Top Healthcare Stocks: Icon (ICLR), IDEAYA Biosciences (IDYA)

- TipRanks. All rights reserved.

Thu, 27 Jan 2022 16:35 GMT Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Icon (ICLR) and PDS Biotechnology (PDSB)

- TipRanks. All rights reserved.

Wed, 19 Jan 2022 12:36 GMT Icon (ICLR) Gets a Buy Rating from Mizuho Securities

- TipRanks. All rights reserved.

News

Stocktwits